FDA Amends In-Vivo Option for Showing Bioequivalence to Durezol

The revision comes after Alcon and Novartis petitioned the FDA to apply stricter requirements on bioequivalence studies. Read More

New Bill Would Harmonize FDA Device Inspections

The bill would adopt a risk-based approach to inspections. Read More
The Solutions Center